We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » KV Settlement Is a Warning on False Claims, Unapproved Drugs
KV Settlement Is a Warning on False Claims, Unapproved Drugs
December 9, 2011
A $17 million deal with KV Pharmaceutical to settle false claims allegations should cue drugmakers to the FDA and Justice Department’s focus on this area, officials say.